{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:45:39Z","timestamp":1792806339551,"version":"4.5.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s10620-025-09457-2","type":"journal-article","created":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T03:57:35Z","timestamp":1760587055000},"page":"1003-1014","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Non-invasive Vagal Nerve Stimulation Decreases the Need for Rescue Medication for Nausea Exacerbation in Patients with Chronic Nausea and Vomiting"],"prefix":"10.1007","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1645-2912","authenticated-orcid":false,"given":"Guillermo","family":"Barahona","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4869-6459","authenticated-orcid":false,"given":"Luisa Villatoro","family":"de Barahona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4626-0015","authenticated-orcid":false,"given":"Samarth S.","family":"Sidhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0915-8416","authenticated-orcid":false,"given":"Robert","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"McKnight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken Y.","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Bulat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4578-6150","authenticated-orcid":false,"given":"Glenn J.","family":"Treisman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8083-9660","authenticated-orcid":false,"given":"Eric","family":"Liebler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5316-4792","authenticated-orcid":false,"given":"Candace K.","family":"McClure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj J.","family":"Pasricha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,16]]},"reference":[{"key":"9457_CR1","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1007\/s10620-017-4633-8","volume":"62","author":"K Bielefeldt","year":"2017","unstructured":"Bielefeldt K. From harmful treatment to secondary gain: adverse event reporting in dyspepsia and gastroparesis. Dig Dis Sci 2017;62:2999\u20133013. https:\/\/doi.org\/10.1007\/s10620-017-4633-8.","journal-title":"Dig Dis Sci"},{"key":"9457_CR2","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.14309\/ajg.0000000000001874","volume":"117","author":"M Camilleri","year":"2022","unstructured":"Camilleri M, Kuo B, Nguyen L et al. ACG clinical guideline: gastroparesis. Am J Gastroenterol 2022;117:1197\u20131220. https:\/\/doi.org\/10.14309\/ajg.0000000000001874.","journal-title":"Am J Gastroenterol"},{"key":"9457_CR3","doi-asserted-by":"publisher","first-page":"3468","DOI":"10.1111\/bcp.15852","volume":"89","author":"PLR Andrews","year":"2023","unstructured":"Andrews PLR, Golding JF, Sanger GJ. An assessment of the effects of neurokinin(1) receptor antagonism against nausea and vomiting: relative efficacy, sites of action and lessons for future drug development. Br J Clin Pharmacol 2023;89:3468\u20133490. https:\/\/doi.org\/10.1111\/bcp.15852.","journal-title":"Br J Clin Pharmacol"},{"key":"9457_CR4","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1111\/apt.17466","volume":"57","author":"GJ Sanger","year":"2023","unstructured":"Sanger GJ, Andrews PLR. Review article: an analysis of the pharmacological rationale for selecting drugs to inhibit vomiting or increase gastric emptying during treatment of gastroparesis. Aliment Pharmacol Ther 2023;57:962\u2013978. https:\/\/doi.org\/10.1111\/apt.17466.","journal-title":"Aliment Pharmacol Ther"},{"key":"9457_CR5","doi-asserted-by":"publisher","first-page":"103059","DOI":"10.1016\/j.autneu.2022.103059","volume":"245","author":"C Varangot-Reille","year":"2023","unstructured":"Varangot-Reille C, Sanger GJ, Andrews PLR et al. Neural networks involved in nausea in adult humans: a systematic review. Auton Neurosci 2023;245:103059. https:\/\/doi.org\/10.1016\/j.autneu.2022.103059.","journal-title":"Auton Neurosci"},{"key":"9457_CR6","doi-asserted-by":"publisher","first-page":"e13769","DOI":"10.1111\/nmo.13769","volume":"32","author":"A Gottfried-Blackmore","year":"2020","unstructured":"Gottfried-Blackmore A, Adler EP, Fernandez-Becker N et al. Open-label pilot study: non-invasive vagal nerve stimulation improves symptoms and gastric emptying in patients with idiopathic gastroparesis. Neurogastroenterol Motil 2020;32:e13769. https:\/\/doi.org\/10.1111\/nmo.13769.","journal-title":"Neurogastroenterol Motil"},{"key":"9457_CR7","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1136\/flgastro-2017-100809","volume":"8","author":"E Paulon","year":"2017","unstructured":"Paulon E, Nastou D, Jaboli F et al. Proof of concept: short-term non-invasive cervical vagus nerve stimulation in patients with drug-refractory gastroparesis. Frontline Gastroenterol 2017;8:325\u2013330. https:\/\/doi.org\/10.1136\/flgastro-2017-100809.","journal-title":"Frontline Gastroenterol"},{"key":"9457_CR8","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1016\/j.cgh.2022.05.022","volume":"20","author":"PJ Pasricha","year":"2022","unstructured":"Pasricha PJ, Grover M, Yates KP et al. Progress in gastroparesis\u2014a narrative review of the work of the gastroparesis clinical research consortium. Clin Gastroenterol Hepatol 2022;20:e3. https:\/\/doi.org\/10.1016\/j.cgh.2022.05.022.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"9457_CR9","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1007\/s10620-017-4456-7","volume":"62","author":"D Yu","year":"2017","unstructured":"Yu D, Ramsey FV, Norton WF et al. The burdens, concerns, and quality of life of patients with gastroparesis. Dig Dis Sci 2017;62:879\u2013893. https:\/\/doi.org\/10.1007\/s10620-017-4456-7.","journal-title":"Dig Dis Sci"},{"key":"9457_CR10","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1111\/j.1365-2036.2009.04078.x","volume":"30","author":"DA Revicki","year":"2009","unstructured":"Revicki DA, Camilleri M, Kuo B et al. Development and content validity of a gastroparesis cardinal symptom index daily diary. Aliment Pharmacol Ther 2009;30:670\u2013680. https:\/\/doi.org\/10.1111\/j.1365-2036.2009.04078.x.","journal-title":"Aliment Pharmacol Ther"},{"key":"9457_CR11","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1007\/s11136-004-9567-x","volume":"13","author":"AM Rentz","year":"2004","unstructured":"Rentz AM, Kahrilas P, Stanghellini V et al. Development and psychometric evaluation of the patient assessment of upper gastrointestinal symptom severity index (PAGI-SYM) in patients with upper gastrointestinal disorders. Qual Life Res 2004;13:1737\u20131749. https:\/\/doi.org\/10.1007\/s11136-004-9567-x.","journal-title":"Qual Life Res"},{"key":"9457_CR12","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1046\/j.1365-2036.2003.01612.x","volume":"18","author":"DA Revicki","year":"2003","unstructured":"Revicki DA, Rentz AM, Dubois D et al. Development and validation of a patient-assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index. Aliment Pharmacol Ther 2003;18:141\u2013150. https:\/\/doi.org\/10.1046\/j.1365-2036.2003.01612.x.","journal-title":"Aliment Pharmacol Ther"},{"key":"9457_CR13","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/BF01535722","volume":"33","author":"J Svedlund","year":"1988","unstructured":"Svedlund J, Sjodin I, Dotevall G. GSRS\u2013a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci 1988;33:129\u2013134. https:\/\/doi.org\/10.1007\/BF01535722.","journal-title":"Dig Dis Sci"},{"key":"9457_CR14","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1016\/j.mayocp.2012.10.013","volume":"87","author":"DM Sletten","year":"2012","unstructured":"Sletten DM, Suarez GA, Low PA et al. COMPASS 31: a refined and abbreviated composite autonomic symptom score. Mayo Clin Proc 2012;87:1196\u20131201. https:\/\/doi.org\/10.1016\/j.mayocp.2012.10.013.","journal-title":"Mayo Clin Proc"},{"key":"9457_CR15","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1111\/j.1365-2036.2009.04082.x","volume":"30","author":"E Soffer","year":"2009","unstructured":"Soffer E, Abell T, Lin Z et al. Review article: gastric electrical stimulation for gastroparesis\u2013physiological foundations, technical aspects and clinical implications. Aliment Pharmacol Ther 2009;30:681\u2013694. https:\/\/doi.org\/10.1111\/j.1365-2036.2009.04082.x.","journal-title":"Aliment Pharmacol Ther"},{"key":"9457_CR16","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.gtc.2014.11.009","volume":"44","author":"WL Hasler","year":"2015","unstructured":"Hasler WL. Symptomatic management for gastroparesis: antiemetics, analgesics, and symptom modulators. Gastroenterol Clin North Am. 2015;44:113\u2013126. https:\/\/doi.org\/10.1016\/j.gtc.2014.11.009.","journal-title":"Gastroenterol Clin North Am."},{"key":"9457_CR17","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/ajg.2012.373","volume":"108","author":"M Camilleri","year":"2013","unstructured":"Camilleri M, Parkman HP, Shafi MA, Abell TL, Gerson L. American College of Gastroenterology: clinical guideline: management of gastroparesis. Am J Gastroenterol. 2013;108:18\u201338. https:\/\/doi.org\/10.1038\/ajg.2012.373.","journal-title":"Am J Gastroenterol."},{"key":"9457_CR18","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.ajem.2009.09.028","volume":"29","author":"TW Barrett","year":"2011","unstructured":"Barrett TW, DiPersio DM, Jenkins CA et al. A randomized, placebo-controlled trial of ondansetron, metoclopramide, and promethazine in adults. Am J Emerg Med. 2011;29:247\u2013255. https:\/\/doi.org\/10.1016\/j.ajem.2009.09.028.","journal-title":"Am J Emerg Med."},{"key":"9457_CR19","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ajem.2005.08.017","volume":"24","author":"D Braude","year":"2006","unstructured":"Braude D, Soliz T, Crandall C, Hendey G, Andrews J, Weichenthal L. Antiemetics in the ED: a randomized controlled trial comparing 3 common agents. Am J Emerg Med. 2006;24:177\u2013182. https:\/\/doi.org\/10.1016\/j.ajem.2005.08.017.","journal-title":"Am J Emerg Med."},{"key":"9457_CR20","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1016\/j.bbmt.2018.06.005","volume":"24","author":"AB Clemmons","year":"2018","unstructured":"Clemmons AB, Orr J, Andrick B et al. Randomized, Placebo-Controlled, Phase III Trial of Fosaprepitant, Ondansetron, Dexamethasone (FOND) Versus FOND Plus Olanzapine (FOND-O) for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients with Hematologic Malignancies Receiving Highly Emetogenic Chemotherapy and Hematopoietic Cell Transplantation Regimens: The FOND-O Trial. Biol Blood Marrow Transplant 2018;24:2065\u20132071. https:\/\/doi.org\/10.1016\/j.bbmt.2018.06.005.","journal-title":"Biol Blood Marrow Transplant"},{"key":"9457_CR21","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.cell.2018.10.018","volume":"175","author":"W Han","year":"2018","unstructured":"Han W, Tellez LA, Perkins MH et al. A neural circuit for gut-induced reward. Cell 2018;175:887\u2013888. https:\/\/doi.org\/10.1016\/j.cell.2018.10.018.","journal-title":"Cell"},{"key":"9457_CR22","doi-asserted-by":"publisher","first-page":"103038","DOI":"10.1016\/j.autneu.2022.103038","volume":"243","author":"MJ Hilz","year":"2022","unstructured":"Hilz MJ. Transcutaneous vagus nerve stimulation\u2014a brief introduction and overview. Auton Neurosci 2022;243:103038. https:\/\/doi.org\/10.1016\/j.autneu.2022.103038.","journal-title":"Auton Neurosci"},{"key":"9457_CR23","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1007\/s00125-024-06129-0","volume":"67","author":"DS Kornum","year":"2024","unstructured":"Kornum DS, Bertoli D, Kufaishi H et al. Transcutaneous vagal nerve stimulation for treating gastrointestinal symptoms in individuals with diabetes: a randomised, double-blind, sham-controlled, multicentre trial. Diabetologia 2024;67:1122\u20131137. https:\/\/doi.org\/10.1007\/s00125-024-06129-0.","journal-title":"Diabetologia"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-09457-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-025-09457-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-09457-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:11:10Z","timestamp":1773292270000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-025-09457-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,16]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["9457"],"URL":"https:\/\/doi.org\/10.1007\/s10620-025-09457-2","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,16]]},"assertion":[{"value":"11 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Eric Liebler is a consultant for and owns stock in electroCore, Inc.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study, titled \u201cNon-invasive vagal nerve stimulation (nVNS) for symptomatic exacerbation of nausea in patients with gastroparesis and related disorders,\u201d was conducted in accordance with the ethical guidelines and regulations set forth by the Johns Hopkins University Institutional Review Board (IRB). This study was performed in line with the principles of the declaration of Helsinki. The research was approved under Protocol ID IRB00265410 on March 10, 2021. The study is registered with ClinicalTrials.gov under the identifier NCT04857281. All participants provided informed consent prior to their involvement in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}